Morehouse School of Medicine
Atlanta, Georgia, 30310, United States
Location status: Recruiting
Location contact
Jesus Luevano Jr., M.D.
PRINCIPAL_INVESTIGATOR
Jesus Luevano, M.D.
CONTACT
Julia Liu, M.D.
CONTACT
Julia Liu, M.D.
SUB_INVESTIGATOR
NCT Number: NCT07215000
The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene glycol). The study aims to enroll approximately 300 patients, who will be randomly assigned to one of the two preparation methods in a 2:1 ratio prior to their scheduled colonoscopy appointments. Surveys will be conducted both before and after the procedures.
This project will be conducted over a 12-month period and seeks to compare patient experience of both preparation methods in an outpatient setting. The study will evaluate the rate of preparation completion, patient satisfaction, tolerance of the solutions, and the endoscopic adequacy of each method.
Eligible participants are patients aged 18 or older with upcoming colonoscopy appointments who can provide informed consent in English or Spanish. There is no health risks associated with this study, as both bowel preparation methods are FDA-approved and commonly used in clinical practice.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 4
Atlanta, Georgia, 30310, United States
Location status: Recruiting
Jesus Luevano Jr., M.D.
PRINCIPAL_INVESTIGATOR
Jesus Luevano, M.D.
CONTACT
Julia Liu, M.D.
CONTACT
Julia Liu, M.D.
SUB_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
large volume liquid prep.
SUFLAVE is a split-dose (2-day) regimen. A total of 2 bottles are required for complete preparation for colonoscopy. You will take 2 bottles of liquid in two separate doses. One dose of SUFLAVE is equal to one bottle plus one flavor enhancing packet.
Other names: polyethylene glycol 3350, sodium sulfaten, potassium chloride, magnesium sulfate
SUTAB comes in a kit that contains two medication bottles and a cup for water. Each bottle contains 12 tablets (pills). You'll take 12 pills (one bottle) with water from the cup the night before your exam. Later that evening, drink two more cups of water. Fill the cup to the line each time. Then, six hours before your exam, repeat all three of those steps.
Time frame: Until the end of the study
Evaluate the patient experience of the two new colon prep options (low volume and tablets) versus conventional bowel prep in an out-patient setting.
Time frame: Until the end of the study
Assess endoscopic adequacy of the three bowel cleansing solutions
Time frame: Until the end of the study
Determine the rate of completion for each colon prep option
Time frame: Until the end of the study
Compare rate of cancelation/missed rate, patient satisfaction and tolerance for the three colon preps.
Contact information is provided by the study sponsor or research team.
Julia J Liu, MD, MSc
CONTACT
Tasha Rhymes, M.S. Ed.
CONTACT
Morehouse School of Medicine
Other
Cleansing Options in Outpatient Setting to Improve Tolerance (COOP SIT) Trial
Acronym: COOP SIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07224750
Adenocarcinoma, Carcinoma
Duarte, California, United States
View Trial DetailsNCT05929820
Colorectal Cancer Screening
Los Angeles, California, United States
View Trial DetailsNCT07608120
Bowel Preparation Solutions, Colonoscopy
Guangzhou, Guangdong, China
View Trial DetailsNCT06741293
Colonic Diseases, Colorectal Cancer (CRC)
Lisbon, Lisbon District, Portugal
View Trial Details